selected publications
-
academic article
-
A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.
Diabetes.
67.
2018
A Prospective Cohort Study in Patients with Type 2 Diabetes Mellitus for Validation of Biomarkers (PROVALID) – Study Design and Baseline Characteristics.
Kidney & Blood Pressure Research.
43.
2018
A3993 Myocardial flow reserve assessed by Cardiac 82Rb PET/CT is associated with albumin excretion in patients with type 1 diabetes.
Journal of Hypertension.
36.
2018
Aldosterone blockade added to renin-angiotensin system blockade to reduce albuminuria – A path for improved renoprotection?.
The American Journal of the Medical Sciences.
355.
2018
Application of urinary proteomics as possible risk predictor of renal and cardiovascular complications in patients with type 2-diabetes and microalbuminuria.
Journal of Diabetes and its Complications.
32.
2018
Arterial-ventricular coupling in type 1 diabetes: arterial stiffness is associated with impaired global longitudinal strain in type 1 diabetes patients—the Thousand & 1 Study.
Acta Diabetologica.
55.
2018
Associations between advanced glycation endproducts and matrix metalloproteinases and its inhibitor in individuals with type 1 diabetes.
Journal of Diabetes and its Complications.
32.
2018
Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception cohort.
Diabetologia.
61.
2018
Burden of Uncontrolled Metabolic Risk Factors and Left Ventricular Structure and Function in Patients With Type 2 Diabetes Mellitus.
Journal of the American Heart Association.
7.
2018
Cardiac repolarization and depolarization in people with Type 1 diabetes with normal ejection fraction and without known heart disease: a case‐control study.
Diabetic Medicine.
35.
2018
Cardiovascular autonomic neuropathy and bone metabolism in Type 1 diabetes.
Diabetic Medicine.
35.
2018
Characteristics of high‐ and low‐risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes.
Diabetic Medicine.
35.
2018
Diagnosis of diabetic kidney disease: state of the art and future perspective.
Kidney International Supplements.
8.
2018
Effects of Bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease.
Journal of Diabetes and its Complications.
32.
2018
Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial.
The Lancet Diabetes & Endocrinology.
6.
2018
Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes – An observational follow-up study.
PLoS ONE.
13.
2018
Higher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and Microalbuminuria.
Diabetes Care.
41.
2018
How Does Risk Screening for Kidney Disease Influence Diabetes Distress?.
Diabetes.
67.
2018
LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: an observer-masked, randomised controlled trial.
The Lancet Diabetes & Endocrinology.
6.
2018
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Diabetes Care.
41.
2018
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Diabetologia.
61.
2018
Novel risk genes identified in a genome-wide association study for coronary artery disease in patients with type 1 diabetes.
Cardiovascular Diabetology.
17.
2018
Presence of micro- and macroalbuminuria and the association with cardiac mechanics in patients with type 2 diabetes.
European Heart Journal - Cardiovascular Imaging.
19.
2018
Prognosis and treatment of diabetic nephropathy: Recent advances and perspectives.
Néphrologie & Thérapeutique.
14.
2018
QT-prolongation in type 1 diabetes is augmented during bradycardia.
Journal of Electrocardiology.
51.
2018
Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised Steno-2 study.
Diabetologia.
61.
2018
SP418COLLAGEN TYPE III DEGRADATION IS ASSOCIATED WITH DETERIORATION OF KIDNEY FUNCTION IN PATIENTS WITH TYPE 2 DIABETES WITH MICROALBUMINURIA..
Nephrology,Dialysis and Transplantation.
33.
2018
Serum uric acid and progression of diabetic nephropathy in type 1 diabetes.
Journal of Diabetes and its Complications.
32.
2018
Stratification of type 2 diabetes based on routine clinical markers.
Diabetes Research and Clinical Practice.
141.
2018
Subclassification of diabetes based on quantitative traits.
Nature Reviews Nephrology.
14.
2018
The effect of uric acid lowering treatment on albuminuria and renal function in Type 1 diabetes: a randomized clinical trial.
Diabetic Medicine.
35.
2018
Type 1 diabetes is associated with T-wave morphology changes. The Thousand & 1 Study.
Journal of Electrocardiology.
51.
2018
Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria.
Cardiovascular Diabetology.
17.
2018
Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patients.
Acta Diabetologica.
55.
2018
A proteomic marker of diabetic nephropathy is associated with mortality in patients with type 2 diabetes.
Artery Research.
20.
2017
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial.
The Lancet Diabetes & Endocrinology.
5.
2017
Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference.
Kidney International.
92.
2017
Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies.
Cardiovascular Diabetology.
16.
2017
Diabetes and Hypertension: A Position Statement by the American Diabetes Association.
Diabetes Care.
40.
2017
Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans.
EBioMedicine.
17.
2017
Effect of large weight reductions on measured and estimated kidney function.
BMC Nephrology.
18.
2017
Effect of weight reductions on estimated kidney function: Post-hoc analysis of two randomized trials.
Journal of Diabetes and its Complications.
31.
2017
Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: A sub‐analysis of a randomized, placebo‐controlled, double‐blind, crossover trial.
Diabetes Obesity and Metabolism.
19.
2017
Epicardial, pericardial and total cardiac fat and cardiovascular disease in type 2 diabetic patients with elevated urinary albumin excretion rate.
European Journal of Preventive Cardiology.
24.
2017
Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes.
Kidney International.
91.
2017
Higher Parathyroid Hormone Level Is Associated With Increased Arterial Stiffness in Type 1 Diabetes.
Diabetes Care.
40.
2017
Higher Plasma Methylglyoxal Levels are Associated with Incident Cardiovascular Disease in Individuals with Type 1 Diabetes: a 12-Year Follow-Up Study.
Diabetes.
66.
2017
Incident microalbuminuria and complement factor mannan‐binding lectin‐associated protein 19 in people with newly diagnosed type 1 diabetes.
Diabetes/Metabolism Research and Reviews.
33.
2017
Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits.
Kidney International.
91.
2017
Marker of type VI collagen formation (Pro-C6) is associated with higher arterial stiffness in type 1 diabetes.
Artery Research.
20.
2017
Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial.
Diabetes Obesity and Metabolism.
19.
2017
Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
Kidney International.
92.
2017
Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study.
Cardiovascular Diabetology.
16.
2017
Pleiotropic effects of liraglutide treatment on renal risk factors in type 2 diabetes: Individual effects of treatment.
Journal of Diabetes and its Complications.
31.
2017
Pooled Analysis of Multiple Crossover Trials To Optimize Individual Therapy Response to Renin-Angiotensin-Aldosterone System Intervention.
Clinical Journal of the American Society of Nephrology.
12.
2017
Predicting albuminuria response to spironolactone treatment with urinary proteomics in patients with type 2 diabetes and hypertension.
Nephrology,Dialysis and Transplantation.
33.
2017
Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker.
Kidney International Reports.
2.
2017
QT-prolongation in type 1 diabetes is augmented during bradycardia.
Journal of Electrocardiology.
50.
2017
Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria.
Cardiovascular Diabetology.
16.
2017
Systems Biology–Derived Biomarkers to Predict Progression of Renal Function Decline in Type 2 Diabetes.
Diabetes Care.
40.
2017
The Genetic Landscape of Renal Complications in Type 1 Diabetes.
Journal of the American Society of Nephrology.
28.
2017
The effect of liraglutide on renal function: A randomized clinical trial.
Diabetes Obesity and Metabolism.
19.
2017
Three‐phase bone scintigraphy for diagnosis of Charcot neuropathic osteoarthropathy in the diabetic foot – does quantitative data improve diagnostic value?.
Clinical Physiology and Functional Imaging.
37.
2017
Toe–brachial index as a predictor of cardiovascular disease and all-cause mortality in people with type 2 diabetes and microalbuminuria.
Diabetologia.
60.
2017
Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer..
Current Pharmaceutical Design.
23.
2017
Variability in response to albuminuria‐lowering drugs: true or random?.
British Journal of Clinical Pharmacology.
83.
2017
[OP.4B.04] URINARY PROTEOMICS PREDICTS MORTALITY IN TYPE 2 DIABETES PATIENTS WITH MICROALBUMINURIA.
Journal of Hypertension.
35.
2017
A urinary proteome-based classifier for the early detection of decline in glomerular filtration..
Nephrology,Dialysis and Transplantation.
32.
2016
Abnormal echocardiography in patients with type 2 diabetes and relation to symptoms and clinical characteristics.
Diabetes and Vascular Disease Research.
13.
2016
Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral loci.
Immunologic Research.
64.
2016
CONTEMPORARY DIABETIC CARDIOMYOPATHY IS CHARACTERIZED BY CONCENTRIC REMODELING AND DIASTOLIC DYSFUNCTION - NOT LEFT VENTRICULAR HYPERTROPHY OR SYSTOLIC DYSFUNCTION.
Journal of the American College of Cardiology.
67.
2016
Cardiac 82Rb PET/CT for fast and non-invasive assessment of microvascular function and structure in asymptomatic patients with type 2 diabetes.
Diabetologia.
59.
2016
Cardiac Autonomic Function Is Associated With the Coronary Microcirculatory Function in Patients With Type 2 Diabetes.
Diabetes.
65.
2016
Cardiac time intervals and the association with 2D-speckle-tracking, tissue Doppler and conventional echocardiography: the Thousand&1 Study.
The International Journal of Cardiovascular Imaging.
32.
2016
Cholesterol remnants and triglycerides are associated with decreased myocardial function in patients with type 2 diabetes.
Cardiovascular Diabetology.
15.
2016
Early myocardial impairment in type 1 diabetes patients without known heart disease assessed with tissue Doppler echocardiography: The Thousand & 1 study.
Diabetes and Vascular Disease Research.
13.
2016
Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis.
BMC Nephrology.
17.
2016
Global Changes in Food Supply and the Obesity Epidemic.
Current Obesity Reports.
5.
2016
High osteoprotegerin is associated with development of foot ulcer in type 1 diabetes.
Journal of Diabetes and its Complications.
30.
2016
Impact of type 2 diabetes and duration of type 2 diabetes on cardiac structure and function.
International Journal of Cardiology.
221.
2016
Impaired coronary microcirculation in type 2 diabetic patients is associated with elevated circulating regulatory T cells and reduced number of IL-21R+ T cells.
Cardiovascular Diabetology.
15.
2016
Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuria.
Journal of Diabetes and its Complications.
30.
2016
Methylglyoxal is associated with changes in kidney function among individuals with screen‐detected Type 2 diabetes mellitus.
Diabetic Medicine.
33.
2016
Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis..
Nephrology,Dialysis and Transplantation.
32.
2016
Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic review.
Journal of the Renin-Angiotensin-Aldosterone System.
17.
2016
Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial.
BMJ Open.
6.
2016
Pulse pressure is not an independent predictor of outcome in type 2 diabetes patients with chronic kidney disease and anemia—the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT).
Journal of Human Hypertension.
30.
2016
Renin angiotensin system blockade reduces urinary levels of soluble urokinase plasminogen activator receptor (suPAR) in patients with type 2 diabetes.
Journal of Diabetes and its Complications.
30.
2016
Retinopathy is associated with impaired myocardial function assessed by advanced echocardiography in type 1 diabetes patients – The Thousand & 1 Study.
Diabetes Research and Clinical Practice.
116.
2016
Self-reported dyspnea is associated with impaired global longitudinal strain in ambulatory type 1 diabetes patients with normal ejection fraction and without known heart disease – The Thousand & 1 Study.
Journal of Diabetes and its Complications.
30.
2016
Serum metabolites predict response to angiotensin II receptor blockers in patients with diabetes mellitus.
Journal of Translational Medicine.
14.
2016
Several Conventional Risk Markers Suggesting Presence of Albuminuria Are Weak Among Rural Africans With Hypertension.
Journal of Clinical Hypertension.
18.
2016
Statins are independently associated with increased HbA1c in type 1 diabetes – The Thousand & 1 Study.
Diabetes Research and Clinical Practice.
111.
2016
The Danish Adult Diabetes Registry.
Clinical Epidemiology.
Volume 8.
2016
Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuria.
Diabetologia.
59.
2016
Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 study..
Nephrology,Dialysis and Transplantation.
32.
2016
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial.
Diabetologia.
59.
2016
suPAR level is associated with myocardial impairment assessed with advanced echocardiography in patients with type 1 diabetes with normal ejection fraction and without known heart disease or end-stage renal disease.
European Journal of Endocrinology.
174.
2016
Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes.
Cardiovascular Diabetology.
14.
2015
Angiogenic microRNAs Linked to Incidence and Progression of Diabetic Retinopathy in Type 1 Diabetes.
Diabetes.
65.
2015
Characterization of renal biomarkers for use in clinical trials: effect of preanalytical processing and qualification using samples from subjects with diabetes.
Drug Design Development and Therapy.
Volume 9.
2015
Cuff inflations do not affect night-time blood pressure.
Blood Pressure Monitoring.
20.
2015
Diabetic kidney disease.
Nature Reviews Disease Primers.
1.
2015
Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides.
Journal of the American Society of Nephrology.
26.
2015
Diagnosis and treatment of early renal disease in patients with type 2 diabetes mellitus: what are the clinical needs?.
Nephrology,Dialysis and Transplantation.
30.
2015
Effect of 4 years subcutaneous insulin infusion treatment on albuminuria, kidney function and HbA1c compared with multiple daily injections: a longitudinal follow‐up study.
Diabetic Medicine.
32.
2015
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.
JAMA.
314.
2015
Effect of Sensor-Augmented Pump Treatment Versus Multiple Daily Injections on Albuminuria: A 1-Year Randomized Study..
The Journal of Clinical Endocrinology & Metabolism.
100.
2015
Effects of 12 weeks of treatment with fermented milk on blood pressure, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind placebo-controlled study.
European Journal of Endocrinology.
172.
2015
Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial.
Diabetes Care.
39.
2015
Elevated Urinary Connective Tissue Growth Factor in Diabetic Nephropathy Is Caused by Local Production and Tubular Dysfunction.
Journal of Diabetes Research.
2015.
2015
Genetic risk factors affecting mitochondrial function are associated with kidney disease in people with Type 1 diabetes.
Diabetic Medicine.
32.
2015
Global Longitudinal Strain Is Not Impaired in Type 1 Diabetes Patients Without Albuminuria The Thousand & 1 Study.
JACC Cardiovascular Imaging.
8.
2015
Glucagon-like peptide 1 receptor agonist (GLP-1 RA): long-term effect on kidney function in patients with type 2 diabetes.
Journal of Diabetes and its Complications.
29.
2015
Glucose-Dependent Insulinotropic Polypeptide Stimulates Osteopontin Expression in the Vasculature via Endothelin-1 and CREB.
Diabetes.
65.
2015
IGFBP-4 Fragments as Markers of Cardiovascular Mortality in Type 1 Diabetes Patients With and Without Nephropathy.
The Journal of Clinical Endocrinology & Metabolism.
100.
2015
Identification of possible adverse drug reactions in clinical notes: The case of glucose-lowering medicines.
Journal of Research in Pharmacy Practice.
4.
2015
Improved cardiorenal prognosis in diabetic nephropathy.
Nature Reviews Nephrology.
11.
2015
Improved prognosis of diabetic nephropathy in type 1 diabetes.
Kidney International.
87.
2015
Increased All-Cause Mortality in Patients With Type 1 Diabetes and High-Expression Mannan-Binding Lectin Genotypes: A 12-Year Follow-up Study.
Diabetes Care.
38.
2015
Increased Plasma Concentrations of Midregional Proatrial Natriuretic Peptide Is Associated With Risk of Cardiorenal Dysfunction in Type 1 Diabetes.
American Journal of Hypertension.
28.
2015
Microalbuminuria: A parameter that has changed diabetes care.
Diabetes Research and Clinical Practice.
107.
2015
PP.33.30.
Journal of Hypertension.
33.
2015
PP.33.31.
Journal of Hypertension.
33.
2015
Plasma proteomics classifiers improve risk prediction for renal disease in patients with hypertension or type 2 diabetes.
Journal of Hypertension.
33.
2015
Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes.
Nephrology,Dialysis and Transplantation.
30.
2015
SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetes.
Diabetologia.
58.
2015
Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.
Journal of Internal Medicine.
277.
2015
The CKD273 urinary proteomic biomarker for early diagnosis of diabetic nephropathy does not indicate generalised subclinical vascular disease in normoalbuminuric type 2 diabetic patients.
Artery Research.
12.
2015
The influence of pharmaceutically induced weight changes on estimates of renal function: A patient-level pooled analysis of seven randomised controlled trials of glucose lowering medication.
Journal of Diabetes and its Complications.
29.
2015
The renal protective effect of angiotensin receptor blockers depends on intra‐individual response variation in multiple risk markers.
British Journal of Clinical Pharmacology.
80.
2015
Time course and mechanisms of the anti‐hypertensive and renal effects of liraglutide treatment.
Diabetic Medicine.
32.
2015
Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial.
Diabetic Medicine.
32.
2015
Association of the pattern recognition molecule H-ficolin with incident microalbuminuria in an inception cohort of newly diagnosed type 1 diabetic patients: an 18 year follow-up study.
Diabetologia.
57.
2014
Cardiac 82Rb-PET/CT reveals microvascular dysfunction in asymptomatic patients with type 2 diabetes.
Artery Research.
8.
2014
Cause-Specific Mortality According to Urine Albumin Creatinine Ratio in the General Population.
PLoS ONE.
9.
2014
Central Hemodynamics Are Associated With Cardiovascular Disease and Albuminuria in Type 1 Diabetes.
American Journal of Hypertension.
27.
2014
Glomerular filtration rate estimation using cystatin C alone or combined with creatinine as a confirmatory test.
Nephrology,Dialysis and Transplantation.
29.
2014
Improved Survival and Renal Prognosis of Patients With Type 2 Diabetes and Nephropathy With Improved Control of Risk Factors.
Diabetes Care.
37.
2014
Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.
Nephrology,Dialysis and Transplantation.
29.
2014
Prevalence of systolic and diastolic dysfunction in patients with type 1 diabetes without known heart disease: the Thousand & 1 Study.
Diabetologia.
57.
2014
Pulse wave reflection is associated with diabetes duration, albuminuria and cardiovascular disease in type 1 diabetes.
Acta Diabetologica.
51.
2014
Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy.
American Journal of Nephrology.
40.
2014
Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia.
BMJ Open Diabetes Research & Care.
2.
2014
Sequential RAAS Blockade: Is It Worth the Risk?.
Advances in Chronic Kidney Disease.
21.
2014
Treatment with continuous subcutaneous insulin infusion is associated with lower arterial stiffness.
Acta Diabetologica.
51.
2014
Urinary Alpha- and Pi-Glutathione S-Transferases in Adult Patients with Type 1 Diabetes.
Nephron Extra.
4.
2014
Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus.
Diabetic Medicine.
31.
2014
-
chapter
-
Clinical Features and Natural Course of Diabetic Nephropathy.
Springer Nature.
2019
-
dataset
-
Data_Sheet_1_Metabolomic Assessment Reveals Alteration in Polyols and Branched Chain Amino Acids Associated With Present and Future Renal Impairment in a Discovery Cohort of 637 Persons With Type 1 Diabetes.PDF.
frontiers.
2019
Table_1_Metabolomic Assessment Reveals Alteration in Polyols and Branched Chain Amino Acids Associated With Present and Future Renal Impairment in a Discovery Cohort of 637 Persons With Type 1 Diabetes.docx.
frontiers.
2019
Clinical characteristics of the study population at baseline categorized according to growth differentiation factor 15 and fibroblast growth factor 23 below or above the median..
public-library-of-science.
2018
MOESM1 of Novel risk genes identified in a genome-wide association study for coronary artery disease in patients with type 1 diabetes.
springer-nature.
2018
MOESM5 of Novel risk genes identified in a genome-wide association study for coronary artery disease in patients with type 1 diabetes.
springer-nature.
2018
MOESM6 of Novel risk genes identified in a genome-wide association study for coronary artery disease in patients with type 1 diabetes.
springer-nature.
2018
Stepwise Cox regression analyses: Biomarkers in relation to risk of fatal and nonfatal cardiovascular events, all-cause mortality and decline in eGFR >30% in 200 patients..
public-library-of-science.
2018
Supplementary Material for: A Prospective Cohort Study in Patients with Type 2 Diabetes Mellitus for Validation of Biomarkers (PROVALID) – Study Design and Baseline Characteristics.
karger-publishers.
2018
Hazard ratios and 95% confidence intervals for the associations between UACR and cause-specific mortality (individuals included = 8,472, person years at risk = 95,598)..
public-library-of-science.
2014
Hazard ratios and 95% confidence intervals for the associations between UACR and cause-specific mortality in the Monica10 study (individuals included = 2,569, person years at risk = 42,412)..
public-library-of-science.
2014
Hazard ratios and 95% confidence intervals for the associations between UACR in quartiles and cause-specific mortality (individuals included = 8,472, person years at risk = 95,598)..
public-library-of-science.
2014
Hazard ratios and 95% confidence intervals for the associations between urine albumin and urine creatinine and all-cause mortality in the Monica10 study (individuals included = 2,569, person years at risk = 42,412)..
public-library-of-science.
2014
Main causes of death during follow-up in the Monica10 and Inter99 studies and UACR..
public-library-of-science.
2014
Urine albumin creatinine status according to baseline characteristics of the study populations..
public-library-of-science.
2014
-
hide from search
-
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes.
Diabetologia.
2013
Urinary adiponectin excretion rises with increasing albuminuria in type 1 diabetes.
Journal of Diabetes and its Complications.
2013
Vitamin D status and 5-year changes in urine albumin creatinine ratio and parathyroid hormone in a general population.
Endocrine.
2013
Characteristics of samples successfully analyzed in each discovery collection and the meta-analyses..
public-library-of-science.
2012
New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes.
public-library-of-science.
2012
Results from discovery, second stage, and combined meta-analysis for supported markers..
public-library-of-science.
2012
Characteristics of patients with diabetes..
public-library-of-science.
2010
Identified and validated diabetes type markers..
public-library-of-science.
2010
Multicentric Validation of Proteomic Biomarkers in Urine Specific for Diabetic Nephropathy.
public-library-of-science.
2010
Patient characteristics (means ± SD) of the PREDICTIONS cohort..
public-library-of-science.
2010
Patient cohort..
public-library-of-science.
2010
Urinary Collagen Fragments Are Significantly Altered in Diabetes: A Link to Pathophysiology.
public-library-of-science.
2010
Effect of Adjunct Metformin Treatment in Patients with Type-1 Diabetes and Persistent Inadequate Glycaemic Control. A Randomized Study.
public-library-of-science.
2008
Effect of metformin versus placebo on follow-up (intermediate and study visit) levels of HbA1c and insulin doses in 72 patients with type-1 diabetes during a one year period..
public-library-of-science.
2008
Inclusion, exclusion and withdrawal criteria.
public-library-of-science.
2008
Metabolism-related variables in 100 patients with type-1 diabetes before and after one year of treatment with metformin or placebo..
public-library-of-science.
2008
Non-hypoglycaemia-related serious adverse events in 100 patients with type-1 diabetes allocated treatment with metformin or placebo for one year..
public-library-of-science.
2008
Reported hypoglycaemic episodes in patients with type-1 diabetes during one year of treatment with metformin or placebo..
public-library-of-science.
2008
Subject characteristics at enrolment (−1 month) for 100 patients with type-1 diabetes..
public-library-of-science.
2008